Is olanzapine clinically effective? A naturalistic outcome survey in two hospital settings

Pharmaceutical Journal

Volumn 269, Issue 7211, 2002, Pages 222-225

  Gilchrist, Anne ^a   Taylor, Mark ^a   Wright, Morag ^a   Drury, Karen ^a   Short, Angela ^a   Steel, Robby ^a   Murray, Patricia ^a   Lawrie, Stephen ^a  

^a NHS LOTHIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEALTH SURVEY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; RELIABILITY; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0037125742     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S. Olanzapine for schizophrenia (Cochrane review). In: The Cochrane Library, Issue 1, Oxford: Update Software Ltd; 2000.
2. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology. A basic science for clinical medicine. Boston: Little, Brown & Co; 1991.
3. Mojtabai R, Nicholson RA. Interrater reliability of ratings of delusions and bizarre delusions. Am J Psychiatry 1995;152: 1804-6.
4. Procyshyn RM, Zerjav S. Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine. Clin Ther 1998;20:1203-17; discussion 1192-3.
5. Ho BC, Miller D, Nopoulos P, Andreasen NC. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia. J Clin Psychiatry 1999; 60: 658-63.
6. Taylor D, Mir S, Mase S. Olanzapine in practice: a prospective naturalistic study. Psych Bulletin 1999;23:178-180.
7. Mountjoy CQ, Baldacchino AM, Stubbs JH. British experience with high-dose olanzapine for treatment-refractory schizophrenia [letter]. Am J Psychiatry 1999;156:158-9.
8. Dursun SM, Gardner DM, Bird DC, Flinn J. Olanzapine for patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study. Can J Psychiatry 1999;44:701-4.
9. Chengappa KN, Sheth S, Brar JS, Parepally H, Marcus S, Gopalani A et al. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions. J Clin Psychiatry 1999;60:373-8.